´ëÇѼÒȱâÇÐȸ Asian Pacific Digestive Week(APDW 2018) in conjunction with the 2nd Korea Digestive Disease Week (KDDW 2018) : 2018-11-17 ±³À°ÀÏÀÚ : 2018-11-17 ±³À°Àå¼Ò : ÄÚ¿¢½º ±×·£µåº¼·ë ¿Ü ´Ù¼ö·ë ±³À°ÁÖÁ¦ : Asian Pacific Digestive Week(APDW 2018) in conjunction with the 2nd Korea Digestive Disease Week (KDDW 2018) ÁÖÃÖ±â°ü : ´ëÇѼÒȱâÇÐȸ ´ã´çÀÚ : »ç¹«±¹ ¿¬¶ôó : 02-3471-8555 À̸ÞÀÏ : info@apdw2018.org ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, ¿µ»óÀÇÇаú Âü¼®¿¹»óÀοø : 3500¸í Èñ¸ÁÆòÁ¡ : 6Á¡ Áö¿ª : ¼¿ïƯº°½Ã ±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ ¼¼ºÎ¼ö°·á : 600,000¿ø ºñ°í * Á¶±âµî·Ï: Àü¹®ÀÇ/ºÀÁ÷ÀÇ/°³¿øÀÇ 400,000¿ø, Àü°øÀÇ/ÀüÀÓÀÇ/°£È£»ç/¿¬±¸¿ø/±âŸ 200,000¿ø, Accompanying person 100,000¿ø, PG course 100,000¿ø* »çÀüµî·Ï: Àü¹®ÀÇ/ºÀÁ÷ÀÇ/°³¿øÀÇ 500,000¿ø, Àü°øÀÇ/ÀüÀÓÀÇ/°£È£»ç/¿¬±¸¿ø/±âŸ 250,000¿ø, Accompanying person 150,000¿ø, PG course 150,000¿ø* ÇöÀåµî·Ï: Àü¹®ÀÇ/ºÀÁ÷ÀÇ/°³¿øÀÇ 600,000¿ø, Àü°øÀÇ/ÀüÀÓÀÇ/°£È£»ç/¿¬±¸¿ø/±âŸ 300,000¿ø, Accompanying person 150,000¿ø, PG course 200,000¿ø* Hands-on workshop(EUS, ERCP, Colon Insertion Method, ESD, NBI) 30,000¿ø, (ÁöµµÀÎÁõÀÇ, Àü°øÀÇ/ÀüÀÓÀÇ) 20,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ ±³À°½Ã°£ 11-17 GBR101 08:30~08:50 New trends on obesity and NAFLD in Asia Vincent Wong(The Chinese University of Hong Kong) ±³À°½Ã°£ 11-17 GBR101 08:50~09:10 Interactions between bile acids and nuclear receptors in NAFLD David Q.-H. Wang(Albert Einstein College of Medicine) ±³À°½Ã°£ 11-17 GBR101 09:10~09:30 Clinical trial design and optimal endpoints for nonalcoholic steatohepatitis Won Kim(Seoul Metropolitan Government Seoul National University Boramae Medical Center) ±³À°½Ã°£ 11-17 GBR101 09:30~09:50 Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease George Jacob(The University of Sydney) Åä·Ð 11-17 GBR101 09:50~10:00 Q&As () ÈÞ½Ä 11-17 GBR101 10:00~10:30 Coffee Break () ±³À°½Ã°£ 11-17 GBR101 10:30~10:50 Multidisciplinary approach in HCC treatment: various combination strategies and new emerging MTAs in HCC treatment Masao Omata(University of Tokyo) ±³À°½Ã°£ 11-17 GBR101 10:50~11:10 Application of new local ablation therapies in HCC: microwave RFA, cryotherapy, etc Hyunchul Rhim(Samsung Medical Center) ±³À°½Ã°£ 11-17 GBR101 11:10~11:30 Comparision of transarterial approaches in HCC treatment: conventional TACE, DEB-TACE vs TARE ȤÀº Conventional TACE versus new upcoming transarterial treatments in HCC? Jin Wook Chung(Seoul National University Hospital) ±³À°½Ã°£ 11-17 GBR101 11:30~11:50 Immunotherapeutic approaches beyond molecular targeted agents in HCC Thomas Yau(The University of Hong Kong) Åä·Ð 11-17 GBR101 11:50~12:00 Q&As () ½Ä»ç 11-17 12:00~14:00 ½Ä»ç () ±³À°½Ã°£ 11-17 GBR101 14:00~14:20 Evolving definition and treatment paradigms of acute-on-chronic liver failure Shiv K. Sarin(Institute of Liver and Biliary Sciences (ILBS)) ±³À°½Ã°£ 11-17 GBR101 14:20~14:40 Minimal/overt hepatic encephalopathy: diagnostic tools, who should be treated, and how Ray W. Kim(Stanford University School of Medicine) ±³À°½Ã°£ 11-17 GBR101 14:40~15:00 Management of refractory ascites Ashish Kumar(Sir Ganga Ram Hospital) ±³À°½Ã°£ 11-17 GBR101 15:00~15:20 Recent advances in the management of variceal bleeding Yeon Seok Seo(Korea University Anam Hospital) Åä·Ð 11-17 GBR101 15:20~15:30 Q&As () ÈÞ½Ä 11-17 15:30~16:00 Coffee Break () ±³À°½Ã°£ 11-17 GBR101 16:00~16:20 Introduction and overview Nicholas Talley(University of New Castle) ±³À°½Ã°£ 11-17 GBR101 16:20~16:40 Esophageal disorders Hiroto Miwa(Hyogo College of Medicine) ±³À°½Ã°£ 11-17 GBR101 16:40~17:00 Gastroduodenal disorders Nicholas Talley(University of New Castle) ±³À°½Ã°£ 11-17 GBR101 17:00~17:20 Bowel disorders Suck Chei Choi(Wonkwang University Medical Hospital) Åä·Ð 11-17 GBR101 17:20~17:30 Q&As ()
|